# A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

> **NCT00287469** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 2000 (actual)

## Conditions studied

- Hepatitis

## Interventions

- **BIOLOGICAL:** Hepatitis E vaccine, recombinant (Sar 56 kDa)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00287469
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07-09
- **Primary completion:** 2004-01-19
- **Final completion:** 2005-01
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287469, "A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00287469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*